Neusspray Xylometazoline Hcl Htp (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. When sprayed into the nose, it binds to alpha‑adrenergic receptors on the smooth muscle of nasal blood vessels, causing vasoconstriction. This reduces mucosal edema and opens the nasal passages, easing congestion.

The appropriate dose is determined by a qualified healthcare professional based on the patient’s age, condition, and response. Typically, adults and children over a certain age are instructed to spray a specific number of sprays per nostril, not exceeding the recommended daily limit.

Safety data for use in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using this nasal spray.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Neusspray contains Xylometazoline Hydrochloride, an imidazoline‑type decongestant, which offers rapid onset of action similar to phenylephrine‑based sprays. Compared with oxymetazoline, it has a comparable efficacy profile but may have a slightly shorter duration, making it suitable for short‑term relief.

Store the nasal spray at room temperature, away from direct sunlight and moisture. Keep the product in its original packaging until use, and ensure the cap is tightly closed after each application to maintain sterility and potency.

The spray is applied directly into each nostril while the head is upright. The user gently inserts the nozzle into the nostril, presses the pump to deliver the prescribed number of sprays, and then repeats in the other nostril if instructed. Avoid blowing the nose immediately after use.

The most serious risks include rebound nasal congestion (rhinitis medicamentosa) if used longer than recommended, significant elevation of blood pressure, and rare systemic effects such as arrhythmias. Patients should discontinue use and seek medical advice if severe side effects occur.

Individuals with known hypersensitivity to Xylometazoline or any component of the formulation should avoid the product. It is also contraindicated in patients with severe hypertension, coronary artery disease, or those taking monoamine oxidase inhibitors without medical supervision.